These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2132201)

  • 1. Dose-dependent increase in in vitro platelet sensitivity to adenosine-5'-diphosphate in young complication-free diabetic males.
    Davis TM; Bown EG; Turner RC
    Diabetes Res; 1990 Nov; 15(3):103-7. PubMed ID: 2132201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet aggregability in diabetic children: relation to serum lipid and fatty acid composition.
    Ewald U; Kobbah M; Vessby B; Tuvemo T
    Diabetologia; 1983 Nov; 25(5):382-5. PubMed ID: 6653942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function in male diabetics with and without macrovascular complications.
    Tóth L; Szénási P; Jámbor G; Kammerer L; Romics L
    Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.
    Trovati M; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Piretto V; Cavalot F; Anfossi G
    Diabetes; 1995 Nov; 44(11):1318-22. PubMed ID: 7589830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of ADP-induced platelet aggregation in diabetes mellitus.
    Jones DB; Davis TM; Bown E; Carter RD; Mann JI; Prescott RJ
    Diabetologia; 1986 May; 29(5):291-4. PubMed ID: 3721088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics.
    Gin H; Freyburger G; Boisseau M; Aubertin J
    Diabetes Res Clin Pract; 1989 Jan; 6(1):61-7. PubMed ID: 2702918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet shape change abnormalities in diabetic retinopathy.
    Porta M; Hilgard P; Kohner EM
    Diabetologia; 1980 Mar; 18(3):217-21. PubMed ID: 7372026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between fatty acid pattern and platelet aggregation in long-term insulin-dependent type I diabetics.
    Schimke E; Hildebrandt R; Grzeskowiak B
    Biomed Biochim Acta; 1988; 47(10-11):S274-7. PubMed ID: 3248113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostasis variables in type I diabetic patients without demonstrable vascular complications.
    el Khawand C; Jamart J; Donckier J; Chatelain B; Lavenne E; Moriau M; Buysschaert M
    Diabetes Care; 1993 Aug; 16(8):1137-45. PubMed ID: 8375244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some characteristics of spontaneous platelet aggregation in young insulin-dependent diabetic subjects.
    Paulsen EP; McClung NM; Sabio H
    Horm Metab Res Suppl; 1981; 11():15-21. PubMed ID: 6459281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
    Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
    Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography.
    Silberbauer K; Schernthaner G; Sinzinger H; Freyler H
    Atherosclerosis; 1981; 40(1):81-90. PubMed ID: 7284054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombocyte function in children with Type I diabetes mellitus. Cross-sectional study].
    Nowak-Göttl U; Kreuz WD; Besier E; Grüttner HP; Krackhardt B; Breddin HK; Kornhuber B
    Monatsschr Kinderheilkd; 1991 Dec; 139(12):821-5. PubMed ID: 1770958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.